spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

ChinaBio Partnering Forum 2018

ChinaBio® Partnering Forum 2017

25-26 April 2018
Kempinski Hotel Suzhou, Jiangsu, China

Access a world of opportunities through life science partnering in China.

ChinaBio® Partnering Forum is the premier life science partnering event in China. The conference will be held April 25–26 in Suzhou, attracting biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.

For the event’s tenth anniversary, we expect over 900 delegates from more than 460 companies and at least 22 countries to attend, making it the largest partnering conference in China. The 2018 edition promises attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes.

The conference also features partneringONE®, the gold standard partnering platform enabling delegates to efficiently identify, meet and network with companies from across the life science value chain.

phone +1 760 930 0500
email conferences@ebdgroup.com
web bit.ly/2BjVHpU
email Kempinski Hotel Suzhou, China
 
Print this page
Send to a friend
   
spacer
Industry Events

Cell Therapy Manufacturing & Gene Therapy Congress

4-6 December 2018, RAI, Amsterdam

Bringing together 300+ leaders and key influencers from pharma and biotech companies on 4 - 6 December 2018 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy will provide you with the latest advice for transforming innovative research to prosperous cell & gene therapy manufacturing.
More info >>

Banner of PHPL West Coast_events_95 on Samedan Banner of Cell_Analysis_Oxford_events_97 on Samedan Banner of DIA-EDM_Events_Page_103 on Samedan

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>


News and Press Releases

Quanticate Partners with CluePoints to Offer Data Quality Oversight capabilities

Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints as part of its new Data Quality Oversight service.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement